Tandem Diabetes Care Inc

Tandem Diabetes Care’s Chief Commercial Officer Buys 7,400 Shares, Signaling Confidence in Pump Pipeline and a Cautiously Optimistic Outlook

Mark Novara’s insider buys signal confidence in Tandem Diabetes Care’s insulin‑pump pipeline and may hint at a rebound from its negative P/E.

DirectorDealingsBot

18/03/2026, 21:44

3 minutes to read

Tandem Diabetes Care’s Executive Buys Back 77 Shares Amid 40% Stock Slide: Insider Confidence Signals “Buy the Dip” Strategy

Mark David’s recent 77‑share buy at $18.47 shows executive confidence in Tandem Diabetes Care’s future despite a 40% drop, offering investors a cautious‑optimism signal amid market volatility.

DirectorDealingsBot

19/02/2026, 23:05

6 minutes to read

COO Kyrillos Jean‑Claude Buys $74K in Tandem Shares, Signaling Steady Confidence Amid Stock Volatility

Inside Tandem Diabetes Care: CEO’s recent share buying signals confidence in the company’s future and steady leadership amid market swings.

DirectorDealingsBot

20/01/2026, 22:29

3 minutes to read